Ken W. Marshall

Insider Reports History

Location
Warren, NJ
Signature
/s/ Lori Braender, as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ken W. Marshall:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aquestive Therapeutics, Inc. SVP, Chief Commercial Officer Performance Stock Units 75,000 09 Aug 2023 Direct

Insider Reports Filed by Ken W. Marshall

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AQST Aquestive Therapeutics, Inc. 09 Aug 2023 1 $0 4 SVP, Chief Commercial Officer 09 Aug 2023, 16:30
AQST Aquestive Therapeutics, Inc. 05 May 2023 1 $0 4 SVP, Chief Commercial Officer 05 May 2023, 16:00
AQST Aquestive Therapeutics, Inc. 09 Mar 2023 1 $0 4 SVP, Chief Commercial Officer 09 Mar 2023, 14:07
AQST Aquestive Therapeutics, Inc. 04 Nov 2022 1 $0 4 SVP, Chief Commercial Officer 08 Nov 2022, 09:23
AQST Aquestive Therapeutics, Inc. 10 Mar 2022 1 $0 4 SVP, Chief Commercial Officer 14 Mar 2022, 11:25